SPINE
TXA efficacy in perioperative spinal surgery bleeding
This report has been verified
by one or more authors of the
original publication.
Spine J. 2015 Apr 1;15(4):752-761.
This meta-analysis included 11 randomized trials that investigated the effectiveness of intravenous tranexamic acid (TXA) in blood loss reduction during spinal surgery in comparison to a placebo or no treatment group. A total of 644 patients were included from the 11 studies. Pooling of the data found that TXA reduced intraoperative, postoperative, and total blood loss compared to control groups. TXA use also led to a lower incidence of patients requiring blood transfusion.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
